Explore the genomic data gap and how underrepresentation in genetic research affects health equity, diagnostics, and precision medicine.
Learn how genomic profiling identified an EGFR mutation and guided targeted therapy selection in a real-world precision oncology case.
Polygenic risk scores may transform disease prediction, but gaps in genomic diversity continue to limit equity, accuracy, and access in precision medicine across global populations.
Artificial intelligence is reshaping precision medicine by improving diagnostics, predicting treatment response, and enabling more personalized, data-driven healthcare strategies.

A multidisciplinary community committed to advancing research, education, and clinical standards in precision medicine.
Copyright 2026. American Board of Precision Medicine. All Rights Reserved.